Valuation: Bachem Holding AG

Capitalization 4.18B 4.58B 4.42B 3.69B 6.55B 398B 7.31B 49.95B 18.43B 165B 17.16B 16.81B 708B P/E ratio 2024 *
35.3x
P/E ratio 2025 * 29.5x
Enterprise value 4.11B 4.49B 4.34B 3.62B 6.43B 391B 7.18B 49.05B 18.1B 162B 16.85B 16.51B 696B EV / Sales 2024 *
6.69x
EV / Sales 2025 * 5.68x
Free-Float
94.31%
Yield 2024 *
1.55%
Yield 2025 * 1.69%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.61%
1 week-1.22%
Current month-2.82%
1 month+1.79%
3 months-23.71%
6 months-28.15%
Current year-1.90%
More quotes
1 week
55.55
Extreme 55.55
58.30
1 month
54.70
Extreme 54.7
61.25
Current year
54.70
Extreme 54.7
61.25
1 year
54.70
Extreme 54.7
91.65
3 years
49.90
Extreme 49.9
113.80
5 years
29.40
Extreme 29.4
171.00
10 years
8.80
Extreme 8.8
171.00
More quotes
Director TitleAgeSince
Chief Executive Officer 57 31/12/2019
Director of Finance/CFO 48 31/01/2021
Chief Tech/Sci/R&D Officer - 31/12/2002
Manager TitleAgeSince
Chairman 83 -
Director/Board Member 52 12/04/2011
Chairman 69 24/04/2012
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
+1.61%-1.22%-7.37%-44.01% 4.58B
+0.08%-2.19%+35.66%-0.56% 47.29B
-0.69%-6.60%-8.90%-18.25% 34.84B
-0.45%-0.22%+4.01%+22.57% 26.05B
-0.58%+4.19%+72.39%+81.67% 16.55B
-0.17%-5.05%-32.43%-27.33% 15.4B
+1.08%-8.79%-64.09%-78.48% 11.75B
+14.98%+30.36% - - 11.63B
-0.52%-10.13%-0.16%-34.81% 10.66B
+2.56%-4.96%-5.78%+96.89% 10.25B
Average +1.79%-3.57%-0.74%-0.26% 18.9B
Weighted average by Cap. +0.91%-3.11%+7.51%+2.00%
See all sector performances

Financials

2024 *2025 *
Net sales 614M 671M 648M 541M 961M 58.36B 1.07B 7.33B 2.7B 24.25B 2.52B 2.47B 104B 754M 824M 796M 664M 1.18B 71.65B 1.32B 9B 3.32B 29.77B 3.09B 3.03B 128B
Net income 121M 132M 127M 106M 189M 11.47B 211M 1.44B 532M 4.77B 495M 485M 20.43B 141M 154M 148M 124M 220M 13.36B 245M 1.68B 619M 5.55B 576M 565M 23.8B
Net Debt -74.88M -81.91M -79.1M -66M -117M -7.12B -131M -894M -330M -2.96B -307M -301M -12.68B 94.79M 104M 100M 83.54M 148M 9.01B 166M 1.13B 418M 3.74B 389M 381M 16.05B
More financial data * Estimated data
Logo Bachem Holding AG
Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.
Employees
2,009
Calendar
More about the company
Date Price Change Volume
13/02/25 56.55 CHF +1.34% 37,988
12/02/25 55.80 CHF -0.18% 104,393
11/02/25 55.90 CHF -0.36% 87,291
10/02/25 56.10 CHF +0.18% 71,600
07/02/25 56.00 CHF -2.61% 105,437

Delayed Quote Swiss Exchange, February 13, 2025 at 03:41 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
55.80CHF
Average target price
76.00CHF
Spread / Average Target
+36.20%
Consensus

Quarterly revenue - Rate of surprise